Article
Novel insights into FAS defects underlying autoimmune lymphoproliferative syndrome revealed by studies in consanguineous patients.
Journal of leukocyte biology - 1 Mar 2018
Ben-Mustapha Imen, Agrebi Nourhen, Barbouche Mohamed-Ridha
Abstract excerpt
Autoimmune lymphoproliferative syndrome (ALPS) is a primary immunodeficiency disease due to impaired Fas-Fas ligand apoptotic pathway. It is characterized by chronic nonmalignant, noninfectious lymphadenopathy and/or splenomegaly associated with autoimmune manifestations primarily directed against blood cells. Herein, we review the heterogeneous ALPS molecular bases and discuss recent findings revealed by the...
Topics
Join the communities discussing this publication.
